Immune Design snags $49 million VC commitment, expands to Bay Area

Investors promised to pump another $49 million into Immune Design Corp. as the Seattle-based cancer immunotherapy company pushes three therapies into the clinic next year and opens a clinical development center in the Bay Area...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.